Monument Capital Management Sells 75 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Monument Capital Management decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 4.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,639 shares of the semiconductor company’s stock after selling 75 shares during the period. Monument Capital Management’s holdings in Synopsys were worth $796,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in SNPS. Kieckhefer Group LLC purchased a new position in Synopsys during the fourth quarter valued at $27,000. Hazlett Burt & Watson Inc. grew its holdings in Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares during the period. Princeton Global Asset Management LLC purchased a new stake in Synopsys in the third quarter worth about $44,000. nVerses Capital LLC bought a new position in shares of Synopsys during the third quarter valued at approximately $51,000. Finally, Newbridge Financial Services Group Inc. purchased a new position in shares of Synopsys during the fourth quarter valued at approximately $51,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Robert W. Baird reduced their price target on Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Rosenblatt Securities reaffirmed a “buy” rating and issued a $635.00 target price on shares of Synopsys in a report on Wednesday, December 4th. Wells Fargo & Company reduced their price target on shares of Synopsys from $570.00 to $540.00 and set an “equal weight” rating for the company in a research report on Monday, January 13th. Piper Sandler decreased their price target on shares of Synopsys from $670.00 to $655.00 and set an “overweight” rating on the stock in a research report on Friday, December 6th. Finally, Mizuho began coverage on Synopsys in a research report on Tuesday, October 22nd. They set an “outperform” rating and a $650.00 price objective on the stock. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $641.82.

Insider Buying and Selling at Synopsys

In related news, CRO Richard S. Mahoney sold 20,838 shares of the company’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the sale, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.66% of the company’s stock.

Synopsys Trading Down 1.1 %

SNPS opened at $522.53 on Monday. The firm has a market capitalization of $80.77 billion, a PE ratio of 35.99, a P/E/G ratio of 3.49 and a beta of 1.12. The firm has a 50 day moving average of $510.78 and a two-hundred day moving average of $518.00. Synopsys, Inc. has a 12-month low of $457.52 and a 12-month high of $629.38.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.